血糖測定用ストリップ市場：技術別、流通チャネル別-2025-2030年の世界予測

血糖測定用ストリップ市場は、2023年に59億1,000万米ドルと評価され、2024年には63億7,000万米ドルに達すると予測され、CAGR 7.86%で成長し、2030年には100億5,000万米ドルに達すると予測されています。

血糖測定用ストリップは糖尿病管理において極めて重要であり、個人が血糖値を効果的にモニターできるようにします。この市場の範囲は主に、糖尿病患者による個人使用や臨床現場での使用を含むヘルスケア・アプリケーションを包含しています。これらのストリップは糖尿病の診断と管理に不可欠であるため、病院や診療所から在宅医療環境に至るまで幅広い最終用途に対応しています。血糖測定用ストリップの必要性は、ライフスタイルの変化、人口の高齢化、肥満の増加などの要因によって、世界的に糖尿病有病率が上昇していることからも明らかです。主な成長要因としては、ノーコーディングストリップの開発などの技術的発展、健康意識の高まり、糖尿病治療を推進する政府の取り組みなどが挙げられます。さらに、新興市場全体のヘルスケア・インフラの拡大も成長の大きな可能性をもたらしています。しかし、市場拡大は価格圧力、償還問題、厳しい規制基準などの要因によって阻害されています。さらに、持続血糖モニタリングシステムとの競合が課題となっています。患者のコンプライアンスを強化し、個別化医療に対する需要の高まりに対応するために、使いやすく侵襲性の低い検査ソリューションを革新する機会が豊富にあります。企業は、リアルタイムのモニタリングとデータ分析のために、デジタルヘルスプラットフォームと統合された高度な分析機能を備えたストリップの開発に投資することができます。包括的な糖尿病管理ソリューションを提供するためのデジタルヘルス企業との提携も、新たな収益源を開く可能性があります。同市場は革新と研究に大きく傾いており、製品にAIとIoTを統合することで疾病管理に革命をもたらす可能性があることを示唆しています。持続的な成長には、利害関係者との関わりを通じて患者のニーズと規制上の要求を理解することが重要です。企業は戦略的パートナーシップや買収に注力し、新市場に効果的に参入することで、イノベーションと市場競争力を維持するためのコスト効率のバランスを確保すべきです。

市場力学：急速に進化する血糖測定用ストリップ市場の主要市場インサイトを公開

血糖測定用ストリップ市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 糖尿病患者の増加に伴う血糖値の急激な変化を検出する効果的な方法の必要性
  • 糖尿病予防ケアに関する意識
  • 糖尿病用品の購入と使用に関するガイドライン
• 市場抑制要因
  • 高い糖尿病管理コスト
• 市場機会
  • オンライン製品の普及
  • 膨大な糖尿病人口と医療費増加によるアジアの新興経済圏での可能性
• 市場の課題
  • 血糖測定用ストリップの精度不足

ポーターの5つの力：血糖測定用ストリップ市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、血糖測定用ストリップ市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：血糖測定用ストリップ市場における外部からの影響の把握

外部マクロ環境要因は、血糖測定用ストリップ市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析血糖測定用ストリップ市場における競合情勢の把握

血糖測定用ストリップ市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス血糖測定用ストリップ市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、血糖測定用ストリップ市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨血糖測定用ストリップ市場における成功への道筋を描く

血糖測定用ストリップ市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 糖尿病患者の増加に伴い、血糖値の急激な変化を効果的に検出する方法が必要
    • 糖尿病予防ケアに関する意識
    • 糖尿病用品の購入と使用に関するガイドライン
  • 抑制要因
    • 糖尿病管理コストが高い
  • 機会
    • オンラインでの製品入手の急増
    • 糖尿病人口の多さと医療費の増加により、アジアの新興経済には潜在性がある
  • 課題
    • 血糖測定用ストリップの正確性の欠如
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 血糖測定用ストリップ市場：技術別

• チャネルテクノロジー
• ウィッキングテクノロジー

第7章 血糖測定用ストリップ市場：流通チャネル別

• 病院薬局
• オンライン薬局
• 小売薬局

第8章 南北アメリカの血糖測定用ストリップ市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の血糖測定用ストリップ市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの血糖測定用ストリップ市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• A. Menarini Diagnostics s.r.l
• AgaMatrix, Inc.
• B. Braun Medical Ltd
• Bayer AG
• BioSensors, Inc.
• F. Hoffmann-La Roche Ltd
• GlucoRx Limited
• i-SENS Inc
• LifeScan, Inc.
• National Diagnostic Products Pty Ltd
• Nipro Diagnostics UK Limited
• PHC Holdings Corporation
• Spirit Healthcare
• TaiDoc Technology Corporation
• Universal Biosensors Group

LIST OF FIGURES

• FIGURE 1. BLOOD GLUCOSE TEST STRIPS MARKET RESEARCH PROCESS
• FIGURE 2. BLOOD GLUCOSE TEST STRIPS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. BLOOD GLUCOSE TEST STRIPS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. BLOOD GLUCOSE TEST STRIPS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BLOOD GLUCOSE TEST STRIPS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BLOOD GLUCOSE TEST STRIPS MARKET DYNAMICS
• TABLE 7. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CHANNEL TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY WICKING TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 21. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 22. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 33. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 34. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 35. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 70. ITALY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. ITALY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 78. POLAND BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. POLAND BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 80. QATAR BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. QATAR BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 100. BLOOD GLUCOSE TEST STRIPS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 101. BLOOD GLUCOSE TEST STRIPS MARKET, FPNV POSITIONING MATRIX, 2023

The Blood Glucose Test Strips Market was valued at USD 5.91 billion in 2023, expected to reach USD 6.37 billion in 2024, and is projected to grow at a CAGR of 7.86%, to USD 10.05 billion by 2030.

Blood Glucose Test Strips are pivotal in diabetes management, allowing individuals to monitor their blood sugar levels effectively. The scope of this market primarily encompasses healthcare applications, including personal use by diabetics and clinical settings. These strips are essential for diagnosing and managing diabetes, thus catering to a broad end-use scope ranging from hospitals and clinics to home care environments. The necessity of blood glucose test strips is underscored by the rising prevalence of diabetes globally, driven by factors like lifestyle changes, aging populations, and increasing incidences of obesity. Key growth factors include technological advancements such as the development of no-coding strips, increasing health awareness, and government initiatives promoting diabetes care. Moreover, expanding healthcare infrastructure across emerging markets offers an immense potential for growth. However, market expansion is hindered by factors such as pricing pressures, reimbursement issues, and stringent regulatory standards. Additionally, competition from continuous blood glucose monitoring systems poses a challenge. Opportunities abound in innovating user-friendly and minimally invasive testing solutions to enhance patient compliance and meet the growing demand for personalized medicine. Companies can invest in developing strips with advanced analytics capabilities integrated with digital health platforms for real-time monitoring and data analysis. Collaborations with digital health companies to offer comprehensive diabetes management solutions could also open new revenue streams. The market leans heavily towards innovation and research, suggesting that the integration of AI and IoT in product offerings could revolutionize disease management. Understanding patient needs and regulatory demands by engaging with stakeholders will be crucial for sustained growth. Businesses should focus on strategic partnerships and acquisitions to penetrate new markets effectively, ensuring a balance between innovation and cost-efficiency to maintain competitiveness in this evolving landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Glucose Test Strips Market

The Blood Glucose Test Strips Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Need an effective way to detect drastic changes in blood glucose for increasing diabetes cases
  • Awareness about diabetes preventive care
  • Guidelines for buying and using diabetes supplies
• Market Restraints
  • High diabetes management costs
• Market Opportunities
  • Proliferation of online product availability
  • Potential in emerging economies in Asia due to huge diabetic population and increasing health spending
• Market Challenges
  • Lack of accuracy in blood glucose test strips

Porter's Five Forces: A Strategic Tool for Navigating the Blood Glucose Test Strips Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Glucose Test Strips Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Glucose Test Strips Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Glucose Test Strips Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Glucose Test Strips Market

A detailed market share analysis in the Blood Glucose Test Strips Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Glucose Test Strips Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Glucose Test Strips Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Glucose Test Strips Market

A strategic analysis of the Blood Glucose Test Strips Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Glucose Test Strips Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Diagnostics s.r.l, AgaMatrix, Inc., B. Braun Medical Ltd, Bayer AG, BioSensors, Inc., F. Hoffmann-La Roche Ltd, GlucoRx Limited, i-SENS Inc, LifeScan, Inc., National Diagnostic Products Pty Ltd, Nipro Diagnostics UK Limited, PHC Holdings Corporation, Spirit Healthcare, TaiDoc Technology Corporation, and Universal Biosensors Group.

Market Segmentation & Coverage

This research report categorizes the Blood Glucose Test Strips Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Channel Technology and Wicking Technology.
• Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Need an effective way to detect drastic changes in blood glucose for increasing diabetes cases
    • 5.1.1.2. Awareness about diabetes preventive care
    • 5.1.1.3. Guidelines for buying and using diabetes supplies
  • 5.1.2. Restraints
    • 5.1.2.1. High diabetes management costs
  • 5.1.3. Opportunities
    • 5.1.3.1. Proliferation of online product availability
    • 5.1.3.2. Potential in emerging economies in Asia due to huge diabetic population and increasing health spending
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of accuracy in blood glucose test strips
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Blood Glucose Test Strips Market, by Technology

• 6.1. Introduction
• 6.2. Channel Technology
• 6.3. Wicking Technology

7. Blood Glucose Test Strips Market, by Distribution Channel

• 7.1. Introduction
• 7.2. Hospital Pharmacies
• 7.3. Online Pharmacies
• 7.4. Retail Pharmacies

8. Americas Blood Glucose Test Strips Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Blood Glucose Test Strips Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Blood Glucose Test Strips Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. A. Menarini Diagnostics s.r.l
• 2. AgaMatrix, Inc.
• 3. B. Braun Medical Ltd
• 4. Bayer AG
• 5. BioSensors, Inc.
• 6. F. Hoffmann-La Roche Ltd
• 7. GlucoRx Limited
• 8. i-SENS Inc
• 9. LifeScan, Inc.
• 10. National Diagnostic Products Pty Ltd
• 11. Nipro Diagnostics UK Limited
• 12. PHC Holdings Corporation
• 13. Spirit Healthcare
• 14. TaiDoc Technology Corporation
• 15. Universal Biosensors Group